Results 101 to 110 of about 128,590 (274)

Comparison of Epidermal Barrier Integrity in Adults with Classic Atopic Dermatitis, Atopic Prurigo and Non-Atopic Prurigo Nodularis. [PDF]

open access: yesBiology (Basel), 2021
Fölster-Holst R   +9 more
europepmc   +1 more source

The microbiome in patients with atopic dermatitis. [PDF]

open access: yes, 2019
As an interface with the environment, the skin is a complex ecosystem colonized by many microorganisms that coexist in an established balance. The cutaneous microbiome inhibits colonization with pathogens, such as Staphylococcus aureus, and is a crucial ...
Gallo, Richard L   +7 more
core  

Type 2 Innate Lymphoid Cells in Allergic Disease. [PDF]

open access: yes, 2013
Type II innate lymphoid cells (ILC2) are a novel population of lineage-negative cells that produce high levels of Th2 cytokines IL-5 and IL-13. ILC2 are found in human respiratory and gastrointestinal tissue as well as in skin.
Doherty, Taylor A   +2 more
core   +2 more sources

Atopic Dermatitis in Childhood and Biomarkers of Male Reproductive Health: A Danish National Birth Cohort Study

open access: yesJEADV Clinical Practice, EarlyView.
This study found no indication of an adverse effect of childhood atopic dermatitis on biomarkers of male reproductive health. On the contrary, we observed some indications of slightly higher sperm concentration and lower follicle‐stimulating hormone (FSH) and luteinizing hormone (LH).
Camilla Lomholt Kjersgaard   +9 more
wiley   +1 more source

The burden of atopic dermatitis in Portuguese patients: an observational study

open access: yesScientific Reports
Atopic dermatitis (AD) is a common inflammatory skin condition that significantly affects patients' lives and imposes both economic and non-economic burdens. The precise societal and individual consequences of AD remain incompletely understood.
Pedro S. Coelho   +5 more
doaj   +1 more source

Prevalence and risk factors for atopic disease in a population of preschool children in Rome: Challenges to early intervention [PDF]

open access: yes, 2016
Background: Allergic diseases are complex identities determined by an interplay of genetic and environmental factors, resulting in the clinical manifestation of the disease.
DE CASTRO, Giovanna   +8 more
core   +1 more source

Successful Treatment of Dupilumab in Two Cases of Refractory Kimura's Disease

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT Kimura disease (KD) is a chronic inflammatory disorder characterized by subcutaneous nodules, cervical lymphadenopathy, hypereosinophilia, and elevated IgE levels. Treatment options are limited. We report two cases of refractory KD successfully treated with dupilumab.
Manon Blaise   +6 more
wiley   +1 more source

ACTIVATED ZINC PYRITHIONE APPLICATION FOR THE ATOPIC DERMATITIS AMONG CHILDREN: MECHANISM OF ACTION, CLINICAL EFFICIENCY

open access: yesПедиатрическая фармакология, 2009
Atopic dermatitis is characterized by the chronic recurrent course and often complicated by the consecutive infection and requires an adequate and regular external treatment. This article is devoted to the overview of the key pharmacodynamic and clinical
F.I. Petrovsky, D.S. Korostovtsev
doaj   +2 more sources

The pH of the skin surface and its impact on the barrier function [PDF]

open access: yes, 2006
The `acid mantle' of the stratum corneum seems to be important for both permeability barrier formation and cutaneous antimicrobial defense. However, the origin of the acidic pH, measurable on the skin surface, remains conjectural.
Abeck D   +41 more
core   +1 more source

Successful Treatment of Erythroderma in a Psoriasis Patient, Developed After Anti‐IL‐17, Anti‐IL‐23 and Anti‐IL‐4/IL‐13 Treatment, With Deucravacitinib

open access: yesJEADV Clinical Practice, EarlyView.
ABSTRACT We present the case of a 79‐year‐old female patient diagnosed with psoriasis who developed paradoxical drug reactions after administration of anti‐IL17 and anti‐IL‐23 inhibitors. Having shifted towards a rather eczematous phenotype, the patient received an anti‐IL‐4/IL‐3 inhibitor, subsequently developing erythroderma.
Tugce Guel   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy